Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Unlabelled: Neonatal screening of phenylketonuria (PKU) and early treatment are fundamental to prevent mental retardation in children. Unfortunately, it has been observed that some neurological sequelae may still be exhibited despite these preventive strategies. Assessment of the neurodevelopment of early treated children may aid in understanding the devastating effect of PKU on the developing brain, so this study aimed to investigate the neurodevelopmental outcome of early-treated children with PKU using Griffiths-III developmental scales. We conducted an observational single-center case-control study on a total of 60 children.  We compared the neurodevelopmental profile of two groups of children (PKU group = 30 and healthy control group = 30) using Griffiths-III developmental scales. Also PKU children were divided into two subgroups according to their phenylalanine level: controlled and uncontrolled. There were significant decreases in the mean of developmental quotients (DQs) of Griffiths-III subscales A, B, C, D, and general development of PKU group. While there was insignificant difference in the DQ of subscale E (gross motor) among the two groups, there was a significant difference between the two PKU subgroups regarding the developmental quotient of subscales A, B, C, E, and general development. Also, there was a statistically significant correlation between phenylalanine (Phe) levels and the mean of DQs of all Griffiths-III subscales.

Conclusion: Early- treated PKU children are at risk of poor neurodevelopmental outcome even if their gross motor function is normal and this defect is negatively correlated with phenylalanine levels.

What Is Known: • PKU is an inborn error of metabolism that causes mental retardation if not treated early. • Neonatal screening and early treatment prevent mental retardation.

What Is New: • Despite neonatal screening and early treatment, PKU children still exhibit mental function impairment. • The Griffiths III developmental scales is the first time to be used to assess mental functions in PKU children.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12354494PMC
http://dx.doi.org/10.1007/s00431-025-06384-2DOI Listing

Publication Analysis

Top Keywords

pku children
16
neonatal screening
12
early treatment
12
developmental scales
12
pku
11
children
9
early treated
8
treated children
8
prevent mental
8
mental retardation
8

Similar Publications

Development of foveal crowding in typically developing children and children with developmental dyslexia.

Vision Res

September 2025

Peking University Sixth Hospital/Institute of Mental Health, Beijing 100191, China; NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China. Electronic address:

Foveal crowding refers to the impaired recognition of a foveal stimulus due to the presence of adjacent flankers. Previous research has produced inconsistent results regarding the maturation of foveal crowding, either at ages 5-7 or remaining elevated from ages 5 to at least 11. We investigated this developmental trajectory using a specialized set of digit stimuli (Pelli fonts) tailored for measuring foveal crowding.

View Article and Find Full Text PDF

Achieving and maintaining metabolic control is critical for children with phenylalanine hydroxylase (PAH) deficiency. This retrospective longitudinal cohort study investigated metabolic control and monitoring frequency of children with PAH deficiency (≤ 12 years) treated at one of 12 pediatric metabolic centres across Canada. We abstracted data from medical charts and analyzed outcomes by age and diagnostic classification, using mixed effects regression.

View Article and Find Full Text PDF

Objective: Impaired Activities of Daily Living (ADL) can have a negative impact on the psychological well-being of older adults. This study categorises ADL into Basic Activities of Daily Living (BADL) and Instrumental Activities of Daily Living (IADL). By utilising nationally representative cross-sectional data, we explore the association between ADL and BADL limitations and depressive symptoms among the elderly population in China.

View Article and Find Full Text PDF

: The rate at which amino acids (AAs) are absorbed from casein glycomacropeptide (CGMP) when given as a protein substitute in phenylketonuria (PKU) is unknown. This three-way randomised, controlled, crossover study aimed to compare the AA absorption profile of phenylalanine (Phe)-free L-amino acids (L-AAs), low-Phe CGMP (CGMP) and casein in healthy adult subjects. : Area under the curve (AUC) was measured over 240 minutes after ingesting one dose of each protein source on three separate occasions, under the same test conditions.

View Article and Find Full Text PDF

Protein substitutes are essential in the dietary management of phenylketonuria (PKU). Transition from first-stage phenylalanine (Phe)-free infant formula to second- and third-stage protein substitutes is carefully managed to meet a child's evolving nutritional needs, feeding abilities, and developmental progression. However, clinical protocols, product access, and reimbursement vary globally.

View Article and Find Full Text PDF